IDEAYA Biosciences' Series B Round

IDEAYA Biosciences raised a round of funding on March 15, 2018.

IDEAYA is an oncology-focused biotechnology company committed to the discovery of synthetic lethality medicines targeting DNA damage and repair for genetically defined patient populations and for enha…

Articles about IDEAYA Biosciences' Series B Round: